MedTrace Logo

A New Approach to a Personalized Patient Blood Management Program (pPBM) in Total Hip Arthroplasty (THA)

NCT02519088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 477

Last updated 2015-10-12

No results posted yet for this study

Summary

The study evaluates the patient related risk and predictive factors concerning perioperative homologous blood cell transfusion (erythrocyte concentrate ) in THA patients in one EndoCert max-certified orthopedic hospital in Germany.

A patient oriented preoperative decision-making algorithm (a personalised Patient Blood Management or pPBM App) will be developed as a new patient-safety blood-sparing strategy.

The aim is to increase the patient safety by using the pPBM App and to reach a more efficient management of resources.

Conditions

  • Postoperative Anemia

Sponsors & Collaborators

  • Krankenhaus der Barmherzigen Brüder Trier

    lead OTHER

Principal Investigators

  • Ion-Andrei Popescu, MD · Krankenhaus der Barmherzigen Brüder Trier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02519088 on ClinicalTrials.gov